Skip to main content
Psychedex
Article

2,5-DMA Facts

Psychedelic; Substituted amphetamine; Serotonin 2A receptor agonist

Description

2,5-DMA (2,5-dimethoxyamphetamine) is a synthetic stimulant of the phenethylamine class. It weakly activates serotonin receptors,[1] producing physical stimulation without the perceptual shifts of classical psychedelics.

Subjective effects include cardiovascular stimulation, muscle tension, tremor, wakefulness, and heightened environmental interest. The experience is entirely physical — a somatic activation without visual, auditory, or cognitive alteration, closer to a moderate amphetamine dose than any classical psychedelic.[2]

2,5-DMA does not produce dependence,[3] and no lethal dose has been established in any species.[4] The primary risk is sympathomimetic overload — elevated heart rate, raised blood pressure, and elevated body temperature at high doses; MAOIs and other serotonergic drugs compound this sharply.

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 10 mgLight40 – 80 mgCommon80 – 160 mgStrong160 – 200 mgHeavy200+ mg

Starts in 30 – 60 minLasts 6 – 8 hours

Body and dependence

Acute toxicity
Low
Chronic toxicity
Low
Physical dependence
None
Psychological dependence
Negligible
Withdrawal
None recorded
Compulsive redosing
Negligible

Tolerance

Builds
Rapid
Fully resets after
8.5 days
Carries over to
DOI; DOB; DOM; DOC; LSD; psilocybin; mescaline

Effectslikely at a common dose

Perception
none likely · 12 possible
Body
Stimulation; Pupil dilation; Wakefulness; +25 possible, including Temperature dysregulation, Excessive sweating, Abnormal heartbeat
Thinking
none likely · 23 possible, including Suggestibility enhancement
Feeling
none likely · 6 possible, including Anxiety, Emotional lability
Self
none likely · 7 possible
Time
none likely · 3 possible, including Temporal disorientation
Awareness
none likely · 2 possible

Who shouldn't take it

Absolute
Cardiovascular disease; Pre-existing hypertension; Cardiac arrhythmias; Pregnancy and lactation; Concurrent MAOI use; Concurrent tramadol use
Relative
Seizure disorders; Concurrent SSRI/SNRI use

Combinations60 recorded

Lethal (1)
MAOIs
Dangerous (28)
Alpha-2 adrenergic receptor antagonist; Anticholinergics; Caffeine; Ephedrine, Pseudoephedrine; GHB, GBL; Local anesthetics; MDMA, Amphetamines; MDMA, MDA; NDRIs (Wellbutrin); NRIs; Opioids; SSRIs; Stimulants; 5-HTP, Tryptophan; Antipsychotics; Buspirone; Dopamine agonists; DXM; GHB, Baclofen; Ibogaine; Ketamine, DXM, PCP; Lithium; NSAIDs; Poppers, Nitrates; and 4 more, see full page
Caution (27)
See full page: psychedex.org/substances/2-5-dma
Not graded (4)
Not listed never means safe.

Seek help immediately if

Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:

  • Very high body temperature; hot, dry skin
  • Seizures
  • Chest pain; fast or irregular heartbeat
  • Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
  • Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
  • Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm

What to do

  1. Stay calm and reassure — remind them they took a drug and the effect will pass
  2. Move to a calm, quiet, safe space with low light; reduce noise and sensory input
  3. Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
  4. Talk them down gently; don't grab or restrain unless they're in danger
  5. For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
  6. If overheating, cool the body; be ready to give rescue breaths / CPR

The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1.a1 · Not medical advice

References

  1. [1]
    ^Hemanth P, Nistala P, Nguyen VT, Eltit JM, Glennon RA, Dukat M (2023) Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors. — Frontiers in Pharmacology doi:10.3389/fphar.2023.1101290
  2. [2]
    ^Shulgin A, Shulgin A (1991) PiHKAL: A Chemical Love Story - Entry #54: 2,5-DMA Link
  3. [3]
    ^Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens — Neuropharmacology doi:10.1016/j.neuropharm.2011.01.017
  4. [4]
    ^WHO Expert Committee on Drug Dependence (1985) 2,5-DMA - ECDD Information Repository Link
Print version
Report an issue